Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B
Clinical trial NCT02496897 · COMPLETED
Trial details
- NCT number
- NCT02496897
- Sponsor
- Altimmune, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-01
- Primary completion
- 2017-10-13
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.